Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neil Everett Martin, M.D.

Concepts (278)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms70201995993.670 Why?
Androgen Antagonists19201811341.550 Why?
Prostatectomy21201916751.530 Why?
Prostate-Specific Antigen17201821321.360 Why?
Brachytherapy15201712620.990 Why?
Radiation Oncology420194360.930 Why?
Kallikreins320182550.910 Why?
Prostate9201712490.910 Why?
Health Status Indicators220159830.850 Why?
Tosyl Compounds220141260.670 Why?
Patient-Centered Care3201612360.630 Why?
Medical Oncology2201514170.620 Why?
Critical Pathways120173670.620 Why?
Quality Indicators, Health Care2201516680.610 Why?
SEER Program18201914940.590 Why?
Antineoplastic Agents, Hormonal5201714600.570 Why?
RNA, Neoplasm220157910.570 Why?
Anilides220143430.550 Why?
Language120199060.520 Why?
Flutamide120121030.520 Why?
Nitriles220146350.500 Why?
Health Status2201537090.490 Why?
Testicular Neoplasms420187110.490 Why?
Radiotherapy5201916500.450 Why?
Complementary Therapies120135240.400 Why?
Adenocarcinoma6201961590.400 Why?
Bone Neoplasms3201723450.370 Why?
Lymphoma, Non-Hodgkin2201312760.350 Why?
Male8020193181000.350 Why?
Phosphatidylinositol 3-Kinases1201526300.330 Why?
Cancer Care Facilities320173720.320 Why?
Testosterone2201422210.320 Why?
Survivors1201517390.320 Why?
Healthcare Disparities6201622710.320 Why?
Aged6320191429440.310 Why?
Neoplasm Staging162019102610.310 Why?
Alkyl and Aryl Transferases12004830.310 Why?
Patient Education as Topic1201522820.300 Why?
African Americans7201644720.300 Why?
Humans8820195987800.290 Why?
Travel220186210.270 Why?
Early Detection of Cancer1201519910.270 Why?
Exercise2201543420.270 Why?
Palliative Care2201724460.250 Why?
Health Behavior1201323680.250 Why?
Salvage Therapy3201711610.240 Why?
Watchful Waiting320194110.240 Why?
Marital Status420154300.230 Why?
Middle Aged5120191947430.230 Why?
European Continental Ancestry Group8201667650.230 Why?
Quality of Life3201584840.230 Why?
PTEN Phosphohydrolase2201510240.210 Why?
Proportional Hazards Models152019117070.210 Why?
Databases, Factual9201964320.210 Why?
Logistic Models112019134940.200 Why?
Divorce12018830.200 Why?
Academic Medical Centers3201724320.190 Why?
Imidazoles1200411740.190 Why?
Diet1201565740.190 Why?
Risk Assessment112018207190.180 Why?
Organizational Case Studies120173080.180 Why?
Treatment Outcome192017534920.180 Why?
United States262019554970.170 Why?
Radiation Injuries2201412330.170 Why?
Radiotherapy, Adjuvant2201817330.170 Why?
Risk Factors202018624410.170 Why?
Smad4 Protein120151490.160 Why?
Vasectomy12014490.160 Why?
Aged, 80 and over212017525130.160 Why?
Tissue Fixation120152430.150 Why?
Paraffin Embedding120153150.150 Why?
Neoplasms, Second Primary320189070.150 Why?
Formaldehyde120153270.150 Why?
Disease-Free Survival5201768380.150 Why?
Urology120173210.150 Why?
Osteopontin120153410.150 Why?
Anus Neoplasms120162490.150 Why?
Neoplasm Recurrence, Local7201672260.140 Why?
Neoplasms, Germ Cell and Embryonal120173990.140 Why?
Immunohistochemistry52015121440.140 Why?
Health Status Disparities2201414100.140 Why?
Time Factors112018402550.140 Why?
Class I Phosphatidylinositol 3-Kinases120167180.140 Why?
Cyclin D1120155300.140 Why?
Delphi Technique120144320.140 Why?
Socioeconomic Factors6201772760.140 Why?
Combined Modality Therapy5201785190.140 Why?
Seminoma120131180.140 Why?
Telephone120165430.140 Why?
Rectum220148310.130 Why?
Medically Uninsured220167140.130 Why?
Gene Expression Profiling4201791900.130 Why?
Nephrectomy120189080.130 Why?
Consensus2201914670.130 Why?
Income3201415230.130 Why?
Organs at Risk120142760.130 Why?
Stromal Cells1201713140.130 Why?
Superoxide Dismutase120156750.130 Why?
Neoplasms52018161860.120 Why?
Endoribonucleases120131880.120 Why?
Prognosis102018253410.120 Why?
Receptor, IGF Type 1120133690.120 Why?
Geriatric Assessment2201710870.120 Why?
Survival Rate72016122520.120 Why?
Follow-Up Studies142018368630.120 Why?
Community Health Services120166480.120 Why?
Neoplasms, Hormone-Dependent120144490.120 Why?
Treatment Refusal120144210.120 Why?
Gene Fusion120122290.120 Why?
Disease Progression62017117420.120 Why?
Radiotherapy, Conformal120145780.120 Why?
Survival Analysis62018101160.120 Why?
Predictive Value of Tests62018141310.120 Why?
Cohort Studies102018342180.110 Why?
Medical Informatics120176690.110 Why?
User-Computer Interface1201714630.110 Why?
Quality of Health Care2201642160.110 Why?
Radiosurgery1201711190.110 Why?
Edema120137180.110 Why?
Sexual Behavior1201916030.110 Why?
beta Carotene120115850.110 Why?
Hyperpigmentation12009880.110 Why?
Guidelines as Topic1201513320.100 Why?
Pancreatic Neoplasms1200442430.100 Why?
Cause of Death6201831670.100 Why?
Enzyme Activation1201540710.100 Why?
Gonadotropin-Releasing Hormone1201411150.100 Why?
Multivariate Analysis62019128260.090 Why?
Dose-Response Relationship, Radiation1200911120.090 Why?
Alopecia120092760.090 Why?
Health Surveys1201738510.090 Why?
Genetic Association Studies2201524260.090 Why?
Retrospective Studies132018523690.090 Why?
Myocardial Infarction32013108030.090 Why?
Serine Endopeptidases1201210480.090 Why?
Insurance Coverage2201414460.090 Why?
Hispanic Americans2201624830.090 Why?
Oncogene Proteins, Fusion1201312680.090 Why?
Age Factors72018180310.080 Why?
Vitamins1201311690.080 Why?
Cost of Illness1201515680.080 Why?
Epithelial Cells1201735320.080 Why?
Farnesyltranstransferase12004900.080 Why?
Odds Ratio5201799750.080 Why?
Patient Acceptance of Health Care1201724430.080 Why?
Incidence72015185190.080 Why?
Antineoplastic Agents32018129130.080 Why?
Weight Gain1201420350.070 Why?
Software1201739520.070 Why?
Anti-Inflammatory Agents1201316270.070 Why?
Cost-Benefit Analysis1201647580.070 Why?
Regression Analysis4201667010.070 Why?
Overweight1201418870.070 Why?
Antioxidants1201117270.070 Why?
Lymph Nodes1201432030.070 Why?
Health Care Costs1201628050.070 Why?
Insurance, Health1201420270.070 Why?
Electronic Health Records1201728570.070 Why?
Risk4201997330.070 Why?
Physicians1201734900.070 Why?
Transcription, Genetic1201781190.070 Why?
Health Services Accessibility1201841420.060 Why?
Carcinoma, Squamous Cell1201636570.060 Why?
Radiation Tolerance220165990.060 Why?
Adult1420171910390.060 Why?
Aspirin1201328850.060 Why?
Drug Therapy, Combination1201262980.060 Why?
Trans-Activators1201231520.060 Why?
Propensity Score2201713800.060 Why?
Heart Failure2201173620.060 Why?
Coronary Artery Bypass1201023960.060 Why?
Quality Improvement1201429260.060 Why?
Biopsy, Needle2201717560.060 Why?
Prospective Studies52015430930.060 Why?
Carrier Proteins1201453310.050 Why?
Infusions, Intravenous1200422850.050 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1201327000.050 Why?
Coronary Disease1201462830.050 Why?
Confidence Intervals2201531510.050 Why?
Ovarian Neoplasms1201543890.050 Why?
RNA, Messenger12015136980.050 Why?
Tumor Burden2201517580.050 Why?
Radiotherapy Dosage2201428200.050 Why?
Educational Status2201421930.050 Why?
Feasibility Studies2201741730.050 Why?
National Cancer Institute (U.S.)120171960.050 Why?
Marriage120183310.040 Why?
Organ Size2201322540.040 Why?
Cryotherapy120171600.040 Why?
Oligonucleotide Array Sequence Analysis2201744090.040 Why?
Delayed Diagnosis120182860.040 Why?
Data Display120162000.040 Why?
Trypsin Inhibitor, Kazal Pancreatic12014230.040 Why?
Goserelin120141260.040 Why?
Minority Health12014620.040 Why?
Survival120131670.040 Why?
Diagnosis-Related Groups120154460.040 Why?
Community Health Centers120173890.040 Why?
Leuprolide120143050.030 Why?
Congresses as Topic120176840.030 Why?
Neoadjuvant Therapy2201318040.030 Why?
Epithelium1201718170.030 Why?
Tissue Array Analysis120146120.030 Why?
Postoperative Complications12014136120.030 Why?
Demography1201615140.030 Why?
Clinical Trials, Phase III as Topic120156410.030 Why?
Obesity12013103960.030 Why?
Lymphoma, Mantle-Cell120131700.030 Why?
Urethra120134440.030 Why?
Signal Transduction12015231100.030 Why?
Area Under Curve1201516220.030 Why?
Dose-Response Relationship, Drug12004115740.030 Why?
Phenotype22018143360.030 Why?
Waist Circumference120137870.030 Why?
Morbidity1201514150.030 Why?
Lymphoma, Follicular120133640.030 Why?
Female920163360140.030 Why?
Epidemiologic Methods1201514480.030 Why?
Qualitative Research1201616660.030 Why?
History, 21st Century1201514190.030 Why?
Gene Expression Regulation, Neoplastic2201778700.030 Why?
Iodine Radioisotopes1201310870.030 Why?
Chemotherapy, Adjuvant1201731280.030 Why?
Randomized Controlled Trials as Topic2201580740.030 Why?
Mortality1201923630.020 Why?
Disease Management1201921280.020 Why?
Sex Distribution1201424480.020 Why?
Germ-Line Mutation1201513700.020 Why?
Cell Line, Tumor12004156290.020 Why?
Lymphatic Metastasis1201529580.020 Why?
Evolution, Molecular1201618870.020 Why?
Radiometry120138120.020 Why?
Angioplasty120104020.020 Why?
Treatment Failure1201324490.020 Why?
History, 20th Century1201528670.020 Why?
Physical Examination1201311710.020 Why?
Neoplasm Invasiveness1201536420.020 Why?
Gene Rearrangement1201211270.020 Why?
Bone and Bones1201723720.020 Why?
Neoplasm Metastasis1201749020.020 Why?
Body Mass Index22014114260.020 Why?
Genetic Predisposition to Disease22018153760.020 Why?
Kaplan-Meier Estimate1201765340.020 Why?
Health Services Needs and Demand1201413570.020 Why?
Continental Population Groups1201519380.020 Why?
Patient Protection and Affordable Care Act120149370.020 Why?
Linear Models1201560300.020 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1201310100.020 Why?
Guideline Adherence1201522210.020 Why?
Young Adult32015469240.020 Why?
Boston1201788920.020 Why?
Analysis of Variance1201468990.020 Why?
Up-Regulation1201343350.020 Why?
Polymorphism, Single Nucleotide22015143820.020 Why?
Social Support1201319300.020 Why?
Biopsy1201562360.020 Why?
Poverty1201420540.020 Why?
Interleukin-61201329040.020 Why?
Genome, Human1201642100.020 Why?
Body Weight1201447390.020 Why?
Drug Resistance, Neoplasm1201644030.020 Why?
Massachusetts1201579430.020 Why?
Radiography1201369800.020 Why?
Health Policy1201324200.020 Why?
C-Reactive Protein1201332520.020 Why?
Registries1201666490.010 Why?
Sex Factors1201499880.010 Why?
Animals120111647310.010 Why?
Comorbidity1201395010.010 Why?
Magnetic Resonance Imaging22016289840.010 Why?
Double-Blind Method12011106350.010 Why?
Stents1201029860.010 Why?
Genotype12013127100.010 Why?
Practice Guidelines as Topic1201367040.010 Why?
Inflammation1201381870.010 Why?
Mutation12016260650.010 Why?
Cardiovascular Diseases12013117510.010 Why?
Adolescent12013757440.010 Why?
Martin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (278)
Explore
_
Co-Authors (91)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.